PKS Competitors

1st Group (ASX:1ST) and PKS (ASX:PKS) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Valuation and Earnings

This table compares 1st Group and PKS's gross revenue, earnings per share and valuation.

PKS has higher revenue and earnings than 1st Group.

Profitability

This table compares 1st Group and PKS's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and target prices for 1st Group and PKS, as reported by MarketBeat.com.

Summary

PKS beats 1st Group on 3 of the 3 factors compared between the two stocks.

PKS (ASX:PKS) and Alcidion Group (ASX:ALC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Profitability

This table compares PKS and Alcidion Group's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations for PKS and Alcidion Group, as provided by MarketBeat.com.

Valuation and Earnings

This table compares PKS and Alcidion Group's revenue, earnings per share and valuation.

PKS has higher earnings, but lower revenue than Alcidion Group.

Summary

PKS beats Alcidion Group on 2 of the 3 factors compared between the two stocks.

PKS (ASX:PKS) and Binovi Technologies (OTCMKTS:BNVIF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings.

Profitability

This table compares PKS and Binovi Technologies' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings for PKS and Binovi Technologies, as provided by MarketBeat.

Valuation & Earnings

This table compares PKS and Binovi Technologies' revenue, earnings per share and valuation.

PKS has higher revenue and earnings than Binovi Technologies.

Summary

PKS beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Cann American (CNSX:CNNA) and PKS (ASX:PKS) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends.

Profitability

This table compares Cann American and PKS's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Cann American and PKS's top-line revenue, earnings per share (EPS) and valuation.

PKS has higher revenue and earnings than Cann American.

Analyst Recommendations

This is a summary of current ratings and target prices for Cann American and PKS, as reported by MarketBeat.com.

Summary

PKS beats Cann American on 1 of the 1 factors compared between the two stocks.

CannaOne Technologies (OTCMKTS:CNONF) and PKS (ASX:PKS) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends.

Profitability

This table compares CannaOne Technologies and PKS's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares CannaOne Technologies and PKS's top-line revenue, earnings per share (EPS) and valuation.

PKS has higher revenue and earnings than CannaOne Technologies.

Analyst Recommendations

This is a summary of current ratings and target prices for CannaOne Technologies and PKS, as reported by MarketBeat.com.

Summary

PKS beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and PKS (ASX:PKS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Analyst Ratings

This is a summary of current ratings and price targets for CloudMD Software & Services and PKS, as reported by MarketBeat.

CloudMD Software & Services currently has a consensus target price of $3.3750, indicating a potential upside of 110.28%.

Profitability

This table compares CloudMD Software & Services and PKS's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares CloudMD Software & Services and PKS's top-line revenue, earnings per share (EPS) and valuation.

PKS has higher revenue and earnings than CloudMD Software & Services.